Why this FTSE 250 stock doubled its share price in 2021

The FTSE 250 stock made incredible gains in 2021 for good reason, but what is in store for it in 2022?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Business development to success and FTSE 100 250 350 growth concept.

Image source: Getty Images

2021 was a great year for many stocks, as recovery resumed. But some stocks clearly outperformed others. One of them is the FTSE 250 opioid addiction treatment provider Indivior (LSE: INDV), whose share price more than doubled during the year. It rose by 135% to be precise. To my mind, the stock was potentially a good one, even when I wrote about it around a year ago. 

Indivior’s improving financials

But I was hesitant to buy it because I was unsure of its financials. I wanted to see more stability before adding it to my investment portfolio. Cut to now, and that is exactly what has happened. For the first nine months of 2021, up to 30 September, it reported a 23% increase in net revenue compared to the same period in 2020. Moreover, it also reported positive net income, which is a comeback after it clocked losses in the year before. In fact, it is now so positive about the full-year 2021, that the company has actually upgraded its guidance for both revenues and pre-tax earnings.

5 Stocks For Trying To Build Wealth After 50

One notable billionaire made 99% of his current wealth after his 50th birthday. And here at The Motley Fool, we believe it is NEVER too late to start trying to build your fortune in the stock market. Our expert Motley Fool analyst team have shortlisted 5 companies that they believe could be a great fit for investors aged 50+ trying to build long-term, diversified portfolios.

Click here to claim your free copy now!

The FTSE 250 stock made gains through 2021

It is little wonder then, that investors gave it a thumbs-up. Its share price started 2021 on a somewhat uncertain note. Indivior had had a difficult year in 2020, when its net revenues had declined and it had swung into a loss. But by April 2021, signs of improvement were visible already, as its revenue started growing once again and it even reported profits.

Its share price continued to rise through the year as it financials improved. And by November last year, the stock was back to levels not seen since 2018. It did take a bit of a wobble in late November and December, when the Omicron variant created fresh panic in the financial markets. But it was able to shrug that off soon enough, and it ended the year at almost the highest levels in the year. 

Potential roadblocks ahead

In 2022 so far, the stock has corrected a bit. This could be correlated with a new report by the US Food and Drug Administration which states that using buprenorphine, a painkiller, in products to treat opioid use could be associated with severe dental problems, including teeth loss. Indivior’s products do use this. This could be playing on investors’ minds for sure. But I think there is more to its recent share price fall than that, because the price was falling even before the report was released. I expect that it could be on account of profit-taking, considering the big gains on the stock in 2021.

My assessment 

In fact, I still think there is upside to the stock. The opioid crisis is a big challenge, so demand for its treatment should stay strong. Moreover, Indivior has resolved its past issues, which included serious consequences from misrepresentation of the safety of its products. Interestingly, all analysts unanimously expect an increase in its share price over the next 12 months, as per a Financial Times compilation, with the average rise expected to be 30%. It goes without saying that all forecasts are subject to change, depending on evolving circumstances. This is particularly so now when we have still not put the pandemic behind us. 

Still, I think this FTSE 250 stock has come a long way. That in itself says a lot about the company’s ability to manage itself. I’d buy it now. 

One Killer Stock For The Cybersecurity Surge

Cybersecurity is surging, with experts predicting that the cybersecurity market will reach US$366 billion by 2028more than double what it is today!

And with that kind of growth, this North American company stands to be the biggest winner.

Because their patented “self-repairing” technology is changing the cybersecurity landscape as we know it…

We think it has the potential to become the next famous tech success story.

In fact, we think it could become as big… or even BIGGER than Shopify.

Click here to see how you can uncover the name of this North American stock that’s taking over Silicon Valley, one device at a time…

Manika Premsingh has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Saucepan on a gas hob
Investing Articles

The Centrica share price is up 65%. Here’s why I sold

The Centrica share price has soared nearly two-thirds in a year. So why has our writer dumped his shareholding?

Read more »

Modern suburban family houses with car on driveway
Investing Articles

As the Howden Joinery share price falls, I’d buy and hold

The Howden Joinery share price has been falling. But Christopher Ruane likes its business model and is weighing adding it…

Read more »

Hand holding pound notes
Investing Articles

The tumbling Persimmon share price means an 11.3% yield! Should I buy?

A falling Persimmon share price has pushed the dividend yield into double-digits. Our writer considers his next move.

Read more »

Innovation and new ideas lightbulb concept 2022
Investing Articles

As stock markets crash, I’d buy these 4 FTSE 100 fallers!

After US stock markets tumbled on Wednesday, the FTSE 100 duly followed suit on Thursday. But falling share prices revealed…

Read more »

Compass pointing towards 'best price'
Investing Articles

A 7.6% dividend yield! Is the Aviva share price a bargain not to be missed?

The Aviva share price has recovered well since the 2020 stock market crash. As one of the top FTSE 100…

Read more »

Hand flipping wooden cubes for change wording" Panic " to " Calm".
Investing Articles

Stock market crash: I’m hunting giants for future gains!

In this latest stock market crash, selling pressure is slamming share prices. But some great company stocks are being crushed,…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

With a P/E of just 8, this social media newcomer is a cheap stock pick!

This social media firm looks like a cheap stock pick for my portfolio. For a growing tech firm, it certainly…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

Warren Buffett has been selling dividend stocks. Should I be doing the same?

As Warren Buffett sells out of Abbvie, Bristol-Myers Squibb, and Verizon, our writer wonders whether he ought to be looking…

Read more »